CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CLNE • US1844991018

2.25 USD
+0.05 (+2.27%)
At close: Feb 3, 2026
2.2492 USD
0 (-0.04%)
After Hours: 2/3/2026, 8:07:28 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLNE. CLNE was compared to 207 industry peers in the Oil, Gas & Consumable Fuels industry. While CLNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CLNE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CLNE was profitable.
  • In the past year CLNE had a positive cash flow from operations.
  • CLNE had negative earnings in each of the past 5 years.
  • CLNE had a positive operating cash flow in each of the past 5 years.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of CLNE (-18.59%) is worse than 88.41% of its industry peers.
  • Looking at the Return On Equity, with a value of -35.75%, CLNE is doing worse than 83.09% of the companies in the same industry.
Industry RankSector Rank
ROA -18.59%
ROE -35.75%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

  • The Gross Margin of CLNE (27.92%) is comparable to the rest of the industry.
  • CLNE's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

  • CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CLNE has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLNE has been increased compared to 5 years ago.
  • The debt/assets ratio for CLNE is higher compared to a year ago.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • CLNE has an Altman-Z score of -0.56. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
  • CLNE has a worse Altman-Z score (-0.56) than 71.50% of its industry peers.
  • The Debt to FCF ratio of CLNE is 9.58, which is on the high side as it means it would take CLNE, 9.58 years of fcf income to pay off all of its debts.
  • CLNE's Debt to FCF ratio of 9.58 is in line compared to the rest of the industry. CLNE outperforms 55.56% of its industry peers.
  • CLNE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.49, CLNE is in line with its industry, outperforming 46.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.58
Altman-Z -0.56
ROIC/WACCN/A
WACC9.45%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • CLNE has a Current Ratio of 2.69. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.69, CLNE belongs to the top of the industry, outperforming 82.13% of the companies in the same industry.
  • CLNE has a Quick Ratio of 2.39. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CLNE (2.39) is better than 82.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.39
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

  • The earnings per share for CLNE have decreased by 0.00% in the last year.
  • Measured over the past years, CLNE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.00% on average per year.
  • CLNE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.04%.
  • CLNE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.86% yearly.
EPS 1Y (TTM)0%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%1.2%

3.2 Future

  • Based on estimates for the next years, CLNE will show a very strong growth in Earnings Per Share. The EPS will grow by 59.91% on average per year.
  • The Revenue is expected to grow by 21.81% on average over the next years. This is a very strong growth
EPS Next Y-165.02%
EPS Next 2Y-72.75%
EPS Next 3Y13.06%
EPS Next 5Y59.91%
Revenue Next Year5.49%
Revenue Next 2Y3.97%
Revenue Next 3Y13.12%
Revenue Next 5Y21.81%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 75.00, CLNE can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLNE indicates a slightly more expensive valuation: CLNE is more expensive than 65.70% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.18, CLNE is valued quite expensively.
  • CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 75
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • 73.43% of the companies in the same industry are cheaper than CLNE, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CLNE is valued a bit cheaper than the industry average as 62.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.45
EV/EBITDA 59.36
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLNE's earnings are expected to grow with 13.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.75%
EPS Next 3Y13.06%

0

5. Dividend

5.1 Amount

  • No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield 0%

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (2/3/2026, 8:07:28 PM)

After market: 2.2492 0 (-0.04%)

2.25

+0.05 (+2.27%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners46.52%
Inst Owner Change-0.73%
Ins Owners1.11%
Ins Owner Change-0.59%
Market Cap493.43M
Revenue(TTM)421.84M
Net Income(TTM)-209.19M
Analysts82.86
Price Target4.84 (115.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)100%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)122.51%
Min EPS beat(4)100%
Max EPS beat(4)184.05%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)114.81%
EPS beat(16)13
Avg EPS beat(16)82.02%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.28%
Max Revenue beat(2)1.54%
Revenue beat(4)4
Avg Revenue beat(4)2.52%
Min Revenue beat(4)0.28%
Max Revenue beat(4)4.45%
Revenue beat(8)6
Avg Revenue beat(8)0.47%
Revenue beat(12)7
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-0.97%
PT rev (1m)0%
PT rev (3m)5.55%
EPS NQ rev (1m)-5.88%
EPS NQ rev (3m)36.47%
EPS NY rev (1m)16.86%
EPS NY rev (3m)72.28%
Revenue NQ rev (1m)2.59%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE 75
Fwd PE N/A
P/S 1.17
P/FCF 16.45
P/OCF 5.23
P/B 0.84
P/tB 0.85
EV/EBITDA 59.36
EPS(TTM)0.03
EY1.33%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.14
FCFY6.08%
OCF(TTM)0.43
OCFY19.11%
SpS1.92
BVpS2.67
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.34
Profitability
Industry RankSector Rank
ROA -18.59%
ROE -35.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.92%
FCFM 7.11%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.58
Debt/EBITDA 34.94
Cap/Depr 65.69%
Cap/Sales 15.24%
Interest Coverage N/A
Cash Conversion 1150.62%
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 2.39
Altman-Z -0.56
F-Score4
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
EPS Next Y-165.02%
EPS Next 2Y-72.75%
EPS Next 3Y13.06%
EPS Next 5Y59.91%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%1.2%
Revenue Next Year5.49%
Revenue Next 2Y3.97%
Revenue Next 3Y13.12%
Revenue Next 5Y21.81%
EBIT growth 1Y-198.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year267.54%
EBIT Next 3Y69.81%
EBIT Next 5Y49.8%
FCF growth 1Y143.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.51%
OCF growth 3Y16.07%
OCF growth 5Y39.37%

CLEAN ENERGY FUELS CORP / CLNE FAQ

What is the fundamental rating for CLNE stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLNE.


What is the valuation status of CLEAN ENERGY FUELS CORP (CLNE) stock?

ChartMill assigns a valuation rating of 1 / 10 to CLEAN ENERGY FUELS CORP (CLNE). This can be considered as Overvalued.


Can you provide the profitability details for CLEAN ENERGY FUELS CORP?

CLEAN ENERGY FUELS CORP (CLNE) has a profitability rating of 2 / 10.


What is the valuation of CLEAN ENERGY FUELS CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CLEAN ENERGY FUELS CORP (CLNE) is 75 and the Price/Book (PB) ratio is 0.84.


What is the earnings growth outlook for CLEAN ENERGY FUELS CORP?

The Earnings per Share (EPS) of CLEAN ENERGY FUELS CORP (CLNE) is expected to decline by -165.02% in the next year.